Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (41)
Marianna Delussi, Christian Valt, Adelchi Silvestri, Katia Ricci, Emanuella Ladisa, Elena Ammendola, Antonio Rampino, Giulio Pergola & Marina de Tommaso. (2024) Auditory mismatch negativity in pre-manifest and manifest Huntington’s disease. Clinical Neurophysiology 162, pages 121-128.
Crossref
Crossref
Jackie M. Poos, Esther van den Berg, Janne M. Papma, Fleur C. van der Tholen, Harro Seelaar, Laura Donker Kaat, J Anneke Kievit, Aad Tibben, John C. van Swieten & Lize C. Jiskoot. (2022) Mindfulness-Based Stress Reduction in Pre-symptomatic Genetic Frontotemporal Dementia: A Pilot Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Filipa Júlio, Gina Caetano, Cristina Januário & Miguel Castelo-Branco. (2019) The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington’s disease individuals. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Radoslawa Herzog–Krzywoszanska & Lukasz Krzywoszanski. (2019) Sleep Disorders in Huntington’s Disease. Frontiers in Psychiatry 10.
Crossref
Crossref
Emma Yhnell, Hannah Furby, Rachel S. Breen, Lucy C. Brookes-Howell, Cheney J. G. Drew, Rebecca Playle, Gareth Watson, Claudia Metzler-Baddeley, Anne E. Rosser & Monica E. Busse. (2018) Exploring computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD): protocol for a randomised feasibility study. Pilot and Feasibility Studies 4:1.
Crossref
Crossref
Emma Yhnell & Andreas Heuer. 2018. Huntington’s Disease. Huntington’s Disease
143
162
.
Flavia R. Silva, Artur S. Miranda, Rebeca P.M. Santos, Isabella G. Olmo, Gerald W. Zamponi, Tomas Dobransky, Jader S. Cruz, Luciene B. Vieira & Fabiola M. Ribeiro. (2017) N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease. Neurobiology of Aging 55, pages 1-10.
Crossref
Crossref
Emma Yhnell, Stephen B. Dunnett & Simon P. Brooks. (2016) A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington’s Disease. PLOS ONE 11:10, pages e0164072.
Crossref
Crossref
Emma Yhnell, Mariah J. Lelos, Stephen B. Dunnett & Simon P. Brooks. (2016) Cognitive training modifies disease symptoms in a mouse model of Huntington's disease. Experimental Neurology 282, pages 19-26.
Crossref
Crossref
Diane R. Nicoll, Eva Pirogovsky, Steven Paul Woods, Heather M. Holden, J. Vincent Filoteo, Shea Gluhm, Jody Corey-Bloom & Paul E. Gilbert. (2013) “Forgetting to Remember” in Huntington's Disease: A Study of Laboratory, Semi-Naturalistic, and Self-Perceptions of Prospective Memory. Journal of the International Neuropsychological Society 20:2, pages 192-199.
Crossref
Crossref
C. Fourie, E. Kim, H. Waldvogel, J. M. Wong, A. McGregor, R. L. M. Faull & J. M. Montgomery. (2014) Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington’s Disease and Parkinson’s Disease Human Brains. Journal of Neurodegenerative Diseases 2014, pages 1-14.
Crossref
Crossref
April L. Philpott, Paul B. Fitzgerald, Tarrant D.R. Cummins & Nellie Georgiou-Karistianis. (2013) Transcranial magnetic stimulation as a tool for understanding neurophysiology in Huntington's disease: A review. Neuroscience & Biobehavioral Reviews 37:8, pages 1420-1433.
Crossref
Crossref
Lan Nguyen, John L. Bradshaw, Julie C. Stout, Rodney J. Croft & Nellie Georgiou-Karistianis. (2010) Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions. Brain Research Reviews 64:1, pages 177-194.
Crossref
Crossref
Perminder S. Sachdev. 2011. Secondary Schizophrenia. Secondary Schizophrenia
348
357
.
Ira Shoulson. 2010. MOVEMENT DISORDERS 4. MOVEMENT DISORDERS 4
432
456
.
Francois Richer, Martin Lemay & Martin Lepage. 2008. Handbook of Episodic Memory. Handbook of Episodic Memory
575
583
.
B. Gómez-AnsónM. AlegretE. MuñozA. SainzG. C. MonteE. Tolosa. (2007) Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Neurology 68:12, pages 906-910.
Crossref
Crossref
Andrea C. Solomon, Julie C. Stout, Shannon A. Johnson, Douglas R. Langbehn, Elizabeth H. Aylward, Jason Brandt, Christopher A. Ross, Leigh Beglinger, Michael R. Hayden, Karl Kieburtz, Elise Kayson, Elaine Julian-Baros, Kevin Duff, Mark Guttman, Martha Nance, David Oakes, Ira Shoulson, Elizabeth Penziner & Jane S. Paulsen. (2007) Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia 45:8, pages 1767-1776.
Crossref
Crossref
Alonso Montoya, Marc Pelletier, Matthew Menear, Elisabeth Duplessis, François Richer & Martin Lepage. (2006) Episodic memory impairment in Huntington's disease: A meta-analysis. Neuropsychologia 44:10, pages 1984-1994.
Crossref
Crossref
Nellie Georgiou-Karistianis, Eleanor Smith, John L Bradshaw, Phyllis Chua, John Lloyd, Andrew Churchyard & Edmond Chiu. (2003) Future directions in research with presymptomatic individuals carrying the gene for Huntington’s disease. Brain Research Bulletin 59:5, pages 331-338.
Crossref
Crossref
Juha O. Rinne, Irina Elovaara & Irina Alafuzoff. 2003. Evidence‐based Dementia Practice. Evidence‐based Dementia Practice
312
329
.
M.D. Lucas, O. H. Turnbull, M. BerkV.U. Fritz. (2002) Predictive Testing for Huntington's Disease: How Does it Impact on Cognitive Performance?. South African Journal of Psychology 32:3, pages 39-47.
Crossref
Crossref
J. Lemiere, M. Decruyenaere, G. Evers-Kiebooms, E. Vandenbussche & R. Dom. (2002) Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurologica Scandinavica 106:3, pages 131-141.
Crossref
Crossref
G. StevaninA. CamuzatS. E. HolmesC. JulienR. SahloulC. DodéV. Hahn-BarmaC. A. RossR. L. MargolisA. DurrA. Brice. (2002) CAG/CTG repeat expansions at the Huntington’s disease–like 2 locus are rare in Huntington’s disease patients. Neurology 58:6, pages 965-967.
Crossref
Crossref
J. S. PaulsenH. ZhaoJ. C. StoutR. R. BrinkmanM. GuttmanC. A. RossP. ComoC. ManningM. R. HaydenI. Shoulson. (2001) Clinical markers of early disease in persons near onset of Huntington’s disease. Neurology 57:4, pages 658-662.
Crossref
Crossref
Joan M. Swearer, Brian F. O'Donnell, Michael Parker, Kevin J. Kane & David A. Drachman. (2016) Psychological features in persons at risk for familial Alzheimer's disease. American Journal of Alzheimer's Disease & Other Dementiasr 16:3, pages 157-162.
Crossref
Crossref
Gary L. Dunbar, Deborah A. Shear, Jie Dong & Kristi L. Haik-Creguer. 2000. Mitochondrial Inhibitors and Neurodegenerative Disorders. Mitochondrial Inhibitors and Neurodegenerative Disorders
73
92
.
Laura L. Murray & Julie C. Stout. (1999) Discourse Comprehension in Huntington’s and Parkinson’s Diseases. American Journal of Speech-Language Pathology 8:2, pages 137-148.
Crossref
Crossref
Deborah A. Shear, Jie Dong, Kristi L. Haik-Creguer, Terence J. Bazzett, Roger L. Albin & Gary L. Dunbar. (1998) Chronic Administration of Quinolinic Acid in the Rat Striatum Causes Spatial Learning Deficits in a Radial Arm Water Maze Task. Experimental Neurology 150:2, pages 305-311.
Crossref
Crossref
Gerly De Boo, Aad Tibben, Jo Hermans, Anneke Maat & Raymund A. C. Roos. (2004) Subtle involuntary movements are not reliable indicators of incipient Huntington's disease. Movement Disorders 13:1, pages 96-99.
Crossref
Crossref
Catherine A. Taylor & Richard H. Myers. (1997) Long-term impact of Huntington disease linkage testing. American Journal of Medical Genetics 70:4, pages 365-370.
Crossref
Crossref
John B. PenneyJrJr, Jean‐Paul Vonsattel, Marcy E. Macdonald, James F. Gusella & Richard H. Myers. (2004) CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 41:5, pages 689-692.
Crossref
Crossref
J R Campodonico, A M Codori & J Brandt. (1996) Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation.. Journal of Neurology, Neurosurgery & Psychiatry 61:6, pages 621-624.
Crossref
Crossref
Stéphane Palfi, Robert J. Ferrante, Emmanuel Brouillet, M. Flint Beal, Robert Dolan, Marie Caroline Guyot, Marc Peschanski & Philippe Hantraye. (1996) Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease. The Journal of Neuroscience 16:9, pages 3019-3025.
Crossref
Crossref
N K Rosenberg, S A Sorensen & A L Christensen. (1995) Neuropsychological characteristics of Huntington's disease carriers: a double blind study.. Journal of Medical Genetics 32:8, pages 600-604.
Crossref
Crossref
A. J. Lundervold & I. Reinvang. (2009) Variability in cognitive function among persons at high genetic risk of Huntington's disease. Acta Neurologica Scandinavica 91:6, pages 462-469.
Crossref
Crossref
L Blackmore, S A Simpson & J R Crawford. (1995) Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease.. Journal of Medical Genetics 32:5, pages 358-362.
Crossref
Crossref
Tatiana Foroud, Eric Siemers, Dawn Kleindorfer, Danield J. Bill, M. E. Hodes, James A. Norton, P. Michael Conneally & Joe C. Christian. (2004) Cognitive scores in carriers of huntington's disease gene compared to noncarriers. Annals of Neurology 37:5, pages 657-664.
Crossref
Crossref
Eleanor Feldman. (2018) The new genetics in psychiatry. Advances in Psychiatric Treatment 1:4, pages 109-115.
Crossref
Crossref
Eric K. Richfield & Miles Herkenham. (2004) Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus. Annals of Neurology 36:4, pages 577-584.
Crossref
Crossref
Mario F. Mendez. (1995) Huntington's Disease: Update and Review of Neuropsychiatric Aspects. The International Journal of Psychiatry in Medicine 24:3, pages 189-208.
Crossref
Crossref